RE:RE:RE:RE:RE:And for the record, I'm on the sidelines, short biasedOn a sidenote it might be interesting for those who plan to stay long to watch James Hodgins comment on Knight Therapeutics on Bnn yesterday. He refers to them being cashed up and ready to profit from the "wreckage" that is Concordia and Valeant, buying the assets on the cheap. Jonathan Goodman is one of the smartest most patient men in pharma. You can go back to his previous CC in July I believe, where he stated he planned to profit from the collapse of certain companies whos business models and debt would likely end them in early 2017. The stars are lining up.
Craigbad wrote: I wouldn't worry about it much as you are a trader Nossy, just enjoy the run. I will back up what I stated though with more clarity. The outrage that triggered UK bill was an investigation in The Times which yielded many articles specifically calling out Amco. They were taking drugs with price controls, changing the name, introducing them as"new" and jacking the price to exploit a loophole. When they were exposed in The Times it sparked a petition, which led to parliament, which led to the health minister to hand files over to the Cma which is an investigative body. Cxr believes the bill won't affect them. I think the bill was largely created due to Amco so i think they're full of it. There are tons of articles in The Times on this matter and if you're staying long it may be worth the time to do some DD.
Nossy45 wrote:
@Craigbad
Assuming the UK Bill would destroy CXR is as speculative as the longs you so criticize. The UK Bill focuses more on older drugs, newer drugs won't be handled the same way. In some cases, they may actually get more for there drugs.